Pub Date : 1999-06-01DOI: 10.1080/17453674.1999.11744822
C S Trovik, H C Bauer
{"title":"Local recurrence after surgery for soft tissue sarcoma. The Scandinavian Sarcoma Group experience.","authors":"C S Trovik, H C Bauer","doi":"10.1080/17453674.1999.11744822","DOIUrl":"https://doi.org/10.1080/17453674.1999.11744822","url":null,"abstract":"","PeriodicalId":75404,"journal":{"name":"Acta orthopaedica Scandinavica. Supplementum","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1999-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17453674.1999.11744822","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21296132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1999-01-01DOI: 10.1080/17453674.1999.11744829
{"title":"List of scientific publications from the Scandinavian Sarcoma Centers, 1992-1998.","authors":"","doi":"10.1080/17453674.1999.11744829","DOIUrl":"https://doi.org/10.1080/17453674.1999.11744829","url":null,"abstract":"","PeriodicalId":75404,"journal":{"name":"Acta orthopaedica Scandinavica. Supplementum","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17453674.1999.11744829","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59946429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1999-01-01DOI: 10.1080/17453674.1999.11744830
J. Thanner
Initial stability is necessary for permanent fixation of acetabular cups. Biologic reactions to submicron particles such as localized bone resorption may lead to implant failure. The aim of the study was to evaluate different fixation principles of acetabular components. Four randomized studies and one case-control study were performed to evaluate different bone cements, different cup designs, use of ceramic coating or not, different type of screws and the need of additional screw fixation or not. Radiostereometry (RSA) makes it possible to analyze small translations and rotations of implants with a high accuracy. This method is suitable for evaluation of early stability and was used in four of the studies. Clinical and radiological follow-up were performed regularly. The cements were tested in the laboratory. 30 patients (mean age 71 years, range: 63-76) received total hip arthroplasties and were randomised to fixation with Boneloc (14) or Palacos cum gentamicin (16) bone cement. The curing temperature was 23 degrees lower for the Boneloc cement but the tensile strength was reduced and the elastic modulus was lower compared to Palacos. The proximal cup migration was greater in the Boneloc group up to 12 months (p 0.04) and these cups migrated medially in contrast to a small lateral migration seen in the Palacos group (p 0.04). Radiolucencies were more pronounced in the Boneloc group at 12 months (p 0.04). 155 patients (171 hips, mean age 50 years, range: 24-64) received uncemented hip arthroplasties. 84 hips were randomised to the PCA and 87 to the Harris-Galante I designs. The 10-year survival rates were 85% for the PCA and 99% for the Harris-Galante I cups (revision as end-point). The wear and clinical results did not differ. 43 patients (mean age 60 years, range 44-68) received uncemented porous cups with a titanium mesh in pure titanium (Harris-Galante II) and were randomised to additional fixation with either biodegradable screws (23, poly-L-lactic acid, PLLA) or screws made of titanium alloy (20). Increased proximal and medial-lateral translations (p 0.02, 0.04) but less rotation around the longitudinal axis (p 0.04) were seen in the PLLA group up to 2 years. There were also more pronounced radiolucencies anteriorly in this group at 2 years. The clinical results did not differ. 23 uncemented porous cups (Harris-Galante II) with hydroxyapatite-tricalciumphosphate coating (HA/TCP) were pair-wise matched to uncoated cups. Up to 2 years, decreased rotations around the horizontal axis were recorded in the HA/TCP-coated cups. Central postoperative gaps were more frequently seen in the HA/TCP group (p < 0.01), but at 2 years radiolucencies were more pronounced in the uncoated group (p < 0.01). The wear and clinical results did not differ. 62 patients (64 hips, mean age 56 years, range: 32-75) were randomized to porous Trilogy cups with (30) and without (34) cluster holes for additional screw fixation. Up to 2 years there were no differences in mi
{"title":"The acetabular component in total hip arthroplasty. Evaluation of different fixation principles.","authors":"J. Thanner","doi":"10.1080/17453674.1999.11744830","DOIUrl":"https://doi.org/10.1080/17453674.1999.11744830","url":null,"abstract":"Initial stability is necessary for permanent fixation of acetabular cups. Biologic reactions to submicron particles such as localized bone resorption may lead to implant failure. The aim of the study was to evaluate different fixation principles of acetabular components. Four randomized studies and one case-control study were performed to evaluate different bone cements, different cup designs, use of ceramic coating or not, different type of screws and the need of additional screw fixation or not. Radiostereometry (RSA) makes it possible to analyze small translations and rotations of implants with a high accuracy. This method is suitable for evaluation of early stability and was used in four of the studies. Clinical and radiological follow-up were performed regularly. The cements were tested in the laboratory. 30 patients (mean age 71 years, range: 63-76) received total hip arthroplasties and were randomised to fixation with Boneloc (14) or Palacos cum gentamicin (16) bone cement. The curing temperature was 23 degrees lower for the Boneloc cement but the tensile strength was reduced and the elastic modulus was lower compared to Palacos. The proximal cup migration was greater in the Boneloc group up to 12 months (p 0.04) and these cups migrated medially in contrast to a small lateral migration seen in the Palacos group (p 0.04). Radiolucencies were more pronounced in the Boneloc group at 12 months (p 0.04). 155 patients (171 hips, mean age 50 years, range: 24-64) received uncemented hip arthroplasties. 84 hips were randomised to the PCA and 87 to the Harris-Galante I designs. The 10-year survival rates were 85% for the PCA and 99% for the Harris-Galante I cups (revision as end-point). The wear and clinical results did not differ. 43 patients (mean age 60 years, range 44-68) received uncemented porous cups with a titanium mesh in pure titanium (Harris-Galante II) and were randomised to additional fixation with either biodegradable screws (23, poly-L-lactic acid, PLLA) or screws made of titanium alloy (20). Increased proximal and medial-lateral translations (p 0.02, 0.04) but less rotation around the longitudinal axis (p 0.04) were seen in the PLLA group up to 2 years. There were also more pronounced radiolucencies anteriorly in this group at 2 years. The clinical results did not differ. 23 uncemented porous cups (Harris-Galante II) with hydroxyapatite-tricalciumphosphate coating (HA/TCP) were pair-wise matched to uncoated cups. Up to 2 years, decreased rotations around the horizontal axis were recorded in the HA/TCP-coated cups. Central postoperative gaps were more frequently seen in the HA/TCP group (p < 0.01), but at 2 years radiolucencies were more pronounced in the uncoated group (p < 0.01). The wear and clinical results did not differ. 62 patients (64 hips, mean age 56 years, range: 32-75) were randomized to porous Trilogy cups with (30) and without (34) cluster holes for additional screw fixation. Up to 2 years there were no differences in mi","PeriodicalId":75404,"journal":{"name":"Acta orthopaedica Scandinavica. Supplementum","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17453674.1999.11744830","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59946439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bone tissue has been shown to contain numerous cell-to-cell signalling peptides called growth factors. These growth factors are thought to have important regulating effects for bone remodeling and bone healing, due to their potent effects on bone cell metabolism. In vivo studies over the last half decade have demonstrated that growth factors candidates for future clinical use in orthopedic surgery. In numerous clinical situations enhanced bone formation and bone healing could lead to improved results of surgical procedures. This thesis describes the most important bone growth factors and their actions in vitro and in vivo. In vitro investigations of growth factor effects on osteoblast chemotaxis and metabolism are described as well as in vivo studies with growth factor stimulation of fracture healing and bone healing to prosthetic-like implants. In vitro results: Several growth factors exhibited chemotactic effects towards human osteoblasts. TGF-beta 1 and PDGF-BB had the strongest chemotactic effects, whereas PDGF-AA, IGF-1, and IGF-2 had less but significant chemotactic effects towards human osteoblasts. TGF-beta 1 exhibited the highest chemotactic potency with maximal activity at 100 pg/mL, whereas the other growth factors had maximal effects at 10-100 ng/mL. BMP-2 was found to have chemotactic effects toward human osteoblasts, human bone marrow osteoprogenitor cells, and U2-OS osteosarcoma cells. BMP-4 and BMP-6 were without any chemotactic effects towards these celltypes. Human bone marrow osteoprogenitor cells were the most responsive celltype to BMP-2 stimulation. Growth factor combinations resulted in synergic stimulative effects on different metabolic functions on human osteoblasts. Combinations with TGF-beta 1 and PDGF-BB strongly stimulated proliferation and chemotaxis. Combinations with TGF-beta 1, PDGF-BB and BMP-2 strongly stimulated an osteoblast differentiation parameter (alkaline phosphatase activity). The different growth factor combinations had no effect on collagen synthesis in human osteoblasts. In vivo results: Continuous application of 1 and 10 micrograms natural TGF-beta to a plated tibial osteotomy in rabbits increased mechanical bending strength and callus formation at 6 weeks observation. Diaphyseal cortical bone remodeling was not affected by the local growth factor application. In a dog model with unloaded implants surrounded by a gap, 0.3 microgram rhTGF-beta 1 adsorbed to gritblasted tricalcium phosphate coated implants, was able to enhance mechanical fixation, bone ingrowth and gap bone formation. 3.0 micrograms rhTGF-beta 1 had less but significant stimulative effect. In a weight-loaded model, 0.3 microgram rhTGF-beta 1, adsorbed to gritblasted tricalcium phosphate coated implants, was able to enhance bone ingrowth, without enhancement of mechanical fixation. In the unloaded model, 0.3 microgram rhTGF-beta 1, adsorbed to gritblasted hydroxyapatite coated implants, was able to enhance bone ingrowth, without e
{"title":"Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation.","authors":"M Lind","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Bone tissue has been shown to contain numerous cell-to-cell signalling peptides called growth factors. These growth factors are thought to have important regulating effects for bone remodeling and bone healing, due to their potent effects on bone cell metabolism. In vivo studies over the last half decade have demonstrated that growth factors candidates for future clinical use in orthopedic surgery. In numerous clinical situations enhanced bone formation and bone healing could lead to improved results of surgical procedures. This thesis describes the most important bone growth factors and their actions in vitro and in vivo. In vitro investigations of growth factor effects on osteoblast chemotaxis and metabolism are described as well as in vivo studies with growth factor stimulation of fracture healing and bone healing to prosthetic-like implants. In vitro results: Several growth factors exhibited chemotactic effects towards human osteoblasts. TGF-beta 1 and PDGF-BB had the strongest chemotactic effects, whereas PDGF-AA, IGF-1, and IGF-2 had less but significant chemotactic effects towards human osteoblasts. TGF-beta 1 exhibited the highest chemotactic potency with maximal activity at 100 pg/mL, whereas the other growth factors had maximal effects at 10-100 ng/mL. BMP-2 was found to have chemotactic effects toward human osteoblasts, human bone marrow osteoprogenitor cells, and U2-OS osteosarcoma cells. BMP-4 and BMP-6 were without any chemotactic effects towards these celltypes. Human bone marrow osteoprogenitor cells were the most responsive celltype to BMP-2 stimulation. Growth factor combinations resulted in synergic stimulative effects on different metabolic functions on human osteoblasts. Combinations with TGF-beta 1 and PDGF-BB strongly stimulated proliferation and chemotaxis. Combinations with TGF-beta 1, PDGF-BB and BMP-2 strongly stimulated an osteoblast differentiation parameter (alkaline phosphatase activity). The different growth factor combinations had no effect on collagen synthesis in human osteoblasts. In vivo results: Continuous application of 1 and 10 micrograms natural TGF-beta to a plated tibial osteotomy in rabbits increased mechanical bending strength and callus formation at 6 weeks observation. Diaphyseal cortical bone remodeling was not affected by the local growth factor application. In a dog model with unloaded implants surrounded by a gap, 0.3 microgram rhTGF-beta 1 adsorbed to gritblasted tricalcium phosphate coated implants, was able to enhance mechanical fixation, bone ingrowth and gap bone formation. 3.0 micrograms rhTGF-beta 1 had less but significant stimulative effect. In a weight-loaded model, 0.3 microgram rhTGF-beta 1, adsorbed to gritblasted tricalcium phosphate coated implants, was able to enhance bone ingrowth, without enhancement of mechanical fixation. In the unloaded model, 0.3 microgram rhTGF-beta 1, adsorbed to gritblasted hydroxyapatite coated implants, was able to enhance bone ingrowth, without e","PeriodicalId":75404,"journal":{"name":"Acta orthopaedica Scandinavica. Supplementum","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1998-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20763903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1998-06-01DOI: 10.1080/17453674.1998.11744790
G B Andersson
{"title":"Epidemiology of low back pain.","authors":"G B Andersson","doi":"10.1080/17453674.1998.11744790","DOIUrl":"https://doi.org/10.1080/17453674.1998.11744790","url":null,"abstract":"","PeriodicalId":75404,"journal":{"name":"Acta orthopaedica Scandinavica. Supplementum","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1998-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17453674.1998.11744790","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20684917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rheumatoid arthritis. A paradigm of inflammatory disease of the musculoskeletal system.","authors":"R N Maini","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":75404,"journal":{"name":"Acta orthopaedica Scandinavica. Supplementum","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1998-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20684913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：